Published in Breast Cancer Res Treat on January 20, 2010
Incidence of breast cancer in the United States: current and future trends. J Natl Cancer Inst (2011) 1.97
Skin cancer screening participation and impact on melanoma incidence in Germany--an observational study on incidence trends in regions with and without population-based screening. Br J Cancer (2012) 1.10
Partnership Status and Socioeconomic Factors in Relation to Health Behavior Changes after a Diagnosis of Ductal Carcinoma In Situ. Cancer Epidemiol Biomarkers Prev (2015) 0.75
Higher-status occupations and breast cancer: a life-course stress approach. Soc Sci Med (2013) 0.75
Time trends in breast cancer incidence and mortality in a mid-sized northeastern Brazilian city. BMC Public Health (2012) 0.75
Expression pattern and methylation of estrogen receptor α in breast intraductal proliferative lesions. Oncol Rep (2016) 0.75
Job Authority and Breast Cancer. Soc Forces (2013) 0.75
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA (2002) 80.37
The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med (2007) 12.23
Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA (1996) 6.53
Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J Natl Cancer Inst (2000) 4.93
Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. J Natl Cancer Inst (1999) 3.35
Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women. Breast Cancer Res (2007) 3.23
Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis. Lancet Oncol (2006) 3.12
Reported drop in mammography : is this cause for concern? Cancer (2007) 2.91
Socioeconomic risk factors for breast cancer: distinguishing individual- and community-level effects. Epidemiology (2004) 2.22
Association of breast cancer and cervical cancer incidence with income and education among whites and blacks. J Natl Cancer Inst (1980) 2.21
Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population. J Clin Oncol (2003) 2.02
Recent incidence trends for breast cancer in women and the relevance of early detection: an update. CA Cancer J Clin (1993) 1.94
Increases in ductal carcinoma in situ (DCIS) of the breast in relation to mammography: a dilemma. J Natl Cancer Inst Monogr (1997) 1.68
Changes in breast cancer incidence rates in the United States by histologic subtype and race/ethnicity, 1995 to 2004. Cancer Epidemiol Biomarkers Prev (2007) 1.67
Breast cancer screening in the United States and Canada, 1994: socioeconomic gradients persist. Am J Public Health (2000) 1.66
Explaining the relation between education and postmenopausal breast cancer. Am J Epidemiol (1997) 1.55
Breast carcinoma in situ: risk factors and screening patterns. J Natl Cancer Inst (2001) 1.26
Risk factors for carcinoma in situ of the breast. Cancer Epidemiol Biomarkers Prev (2000) 1.20
A comparative review of CISNET breast models used to analyze U.S. breast cancer incidence and mortality trends. J Natl Cancer Inst Monogr (2006) 1.15
Changes in women's use of hormones after the Women's Health Initiative estrogen and progestin trial by race, education, and income. J Natl Cancer Inst Monogr (2005) 1.07
The relationship of race/ethnicity and social class to hormone replacement therapy: results from the Third National Health and Nutrition Examination Survey 1988-1994. Menopause (2002) 1.06
Socioeconomic status differences in hormone therapy. Am J Epidemiol (1998) 0.98
Recent trends in breast cancer incidence, mortality, and mammography. Breast Cancer Res Treat (1993) 0.84
Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst (2007) 0.83
Physical activity and survival after diagnosis of invasive breast cancer. Cancer Epidemiol Biomarkers Prev (2008) 3.11
Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Ann Intern Med (2012) 2.85
From menarche to menopause: trends among US Women born from 1912 to 1969. Am J Epidemiol (2006) 2.67
Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers. J Clin Oncol (2011) 2.65
Alcohol consumption before and after breast cancer diagnosis: associations with survival from breast cancer, cardiovascular disease, and other causes. J Clin Oncol (2013) 2.46
The Wisconsin Breast Cancer Epidemiology Simulation Model. J Natl Cancer Inst Monogr (2006) 2.27
Geocoding addresses from a large population-based study: lessons learned. Epidemiology (2003) 2.27
Socioeconomic risk factors for breast cancer: distinguishing individual- and community-level effects. Epidemiology (2004) 2.22
Retrospective cost-effectiveness analysis of screening mammography. J Natl Cancer Inst (2006) 2.19
Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk. Ann Intern Med (2012) 1.99
Toward best practices in radiology reporting. Radiology (2009) 1.84
Recruiting and training leadership through professional societies: a report from the American Society of Preventive Oncology Junior Members Interest Group. Cancer Epidemiol Biomarkers Prev (2006) 1.81
Thyroid cancer incidence and socioeconomic indicators of health care access. Cancer Causes Control (2008) 1.78
Body mass index before and after breast cancer diagnosis: associations with all-cause, breast cancer, and cardiovascular disease mortality. Cancer Epidemiol Biomarkers Prev (2009) 1.75
A sustained decline in postmenopausal hormone use: results from the National Health and Nutrition Examination Survey, 1999-2010. Obstet Gynecol (2012) 1.67
Circulating serum xenoestrogens and mammographic breast density. Breast Cancer Res (2013) 1.65
Socioeconomic status and survival after an invasive breast cancer diagnosis. Cancer (2010) 1.62
Cadmium exposure and breast cancer risk. J Natl Cancer Inst (2006) 1.61
Replication and functional genomic analyses of the breast cancer susceptibility locus at 6q25.1 generalize its importance in women of chinese, Japanese, and European ancestry. Cancer Res (2011) 1.59
Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. Hum Mol Genet (2011) 1.56
Lifetime recreational and occupational physical activity and risk of in situ and invasive breast cancer. Cancer Epidemiol Biomarkers Prev (2007) 1.56
Effects of birth order and maternal age on breast cancer risk: modification by whether women had been breast-fed. Epidemiology (2008) 1.56
Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors. PLoS Genet (2013) 1.56
Postmenopausal estrogen and progestin use in relation to breast cancer risk. Cancer Epidemiol Biomarkers Prev (2002) 1.56
Variation in tumor natural history contributes to racial disparities in breast cancer stage at diagnosis. Breast Cancer Res Treat (2013) 1.53
Alcohol consumption and ovarian cancer risk in a population-based case-control study. Int J Cancer (2006) 1.48
Potential exposure to PCBs, DDT, and PBDEs from sport-caught fish consumption in relation to breast cancer risk in Wisconsin. Environ Health Perspect (2004) 1.47
Postoophorectomy estrogen use and breast cancer risk. Obstet Gynecol (2012) 1.46
Differences in breast cancer risk factors by tumor marker subtypes among premenopausal Vietnamese and Chinese women. Cancer Epidemiol Biomarkers Prev (2005) 1.45
Place of residence and primary treatment of prostate cancer: examining trends in rural and nonrural areas in Wisconsin. Urology (2013) 1.42
Prevalence and treatment of menopausal symptoms among breast cancer survivors. J Pain Symptom Manage (2002) 1.40
Duration of sleep and breast cancer risk in a large population-based case-control study. J Sleep Res (2006) 1.37
Quality of cancer registry data: findings from CDC-NPCR's Breast and Prostate Cancer Data Quality and Patterns of Care Study. J Registry Manag (2011) 1.35
Optimal Breast Biopsy Decision-Making Based on Mammographic Features and Demographic Factors. Oper Res (2010) 1.34
Postmenopausal hormone therapy and risk of breast cancer by histologic type (United States). Cancer Causes Control (2003) 1.32
Rat Mcs5a is a compound quantitative trait locus with orthologous human loci that associate with breast cancer risk. Proc Natl Acad Sci U S A (2007) 1.29
Breast cancer risk estimation with artificial neural networks revisited: discrimination and calibration. Cancer (2010) 1.26
Prediagnostic use of hormone therapy and mortality after breast cancer. Cancer Epidemiol Biomarkers Prev (2008) 1.25
Patient, faculty, and self-assessment of radiology resident performance: a 360-degree method of measuring professionalism and interpersonal/communication skills. Acad Radiol (2004) 1.25
Informatics in radiology: comparison of logistic regression and artificial neural network models in breast cancer risk estimation. Radiographics (2009) 1.23
Early life factors in relation to breast cancer risk in postmenopausal women. Cancer Epidemiol Biomarkers Prev (2002) 1.20
The characteristics and training of professionals in cancer prevention and control: a survey of theAmerican Society for Preventive Oncology. Cancer Epidemiol Biomarkers Prev (2004) 1.18
Body mass index and the risk of death following the diagnosis of colorectal cancer in postmenopausal women (United States). Cancer Causes Control (2006) 1.17
Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status. Epidemiol Rev (2014) 1.17
Oral contraceptive use, reproductive factors, and colorectal cancer risk: findings from Wisconsin. Cancer Epidemiol Biomarkers Prev (2005) 1.14
Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC). PLoS One (2012) 1.13
A logistic regression model based on the national mammography database format to aid breast cancer diagnosis. AJR Am J Roentgenol (2009) 1.11
Social networks and quality of life among female long-term colorectal cancer survivors. Cancer (2003) 1.11
Genetic variation in TP53 and risk of breast cancer in a population-based case control study. Carcinogenesis (2007) 1.10
STK15 polymorphism and breast cancer risk in a population-based study. Carcinogenesis (2004) 1.10
Genetic variation in tumor necrosis factor and lymphotoxin-alpha (TNF-LTA) and breast cancer risk. Hum Genet (2007) 1.10
The Effect of Budgetary Restrictions on Breast Cancer Diagnostic Decisions. Manuf Serv Oper Manag (2012) 1.08
Post-diagnosis dietary factors and survival after invasive breast cancer. Breast Cancer Res Treat (2011) 1.08
Proportion of invasive breast cancer attributable to risk factors modifiable after menopause. Am J Epidemiol (2008) 1.08
Prevalence of breast carcinoma in situ in the United States. JAMA (2009) 1.07
Bilateral oophorectomy in relation to risk of postmenopausal breast cancer: confounding by nonmalignant indications for surgery? Am J Epidemiol (2011) 1.07
Sleep duration and obesity in a population-based study. Sleep Med (2010) 1.06
A case-control study of the HER2 Ile655Val polymorphism in relation to risk of invasive breast cancer. Breast Cancer Res (2005) 1.05
Acculturation and cigarette smoking among pregnant Hispanic women residing in the United States. Am J Public Health (2007) 1.05
Use of antidepressants and NSAIDs in relation to mortality in long-term breast cancer survivors. Pharmacoepidemiol Drug Saf (2010) 1.04
Fluorescence spectroscopy: an adjunct diagnostic tool to image-guided core needle biopsy of the breast. IEEE Trans Biomed Eng (2009) 1.02
Utility of 6-month follow-up imaging after a concordant benign breast biopsy result. Radiology (2010) 1.02
Statin use and risk of breast cancer. Cancer (2008) 1.02
Cancer information sources used by patients to inform and influence treatment decisions. J Health Commun (2010) 1.02
Change in lifestyle behaviors and medication use after a diagnosis of ductal carcinoma in situ. Breast Cancer Res Treat (2010) 1.01
Interpreting data from audits when screening and diagnostic mammography outcomes are combined. AJR Am J Roentgenol (2002) 1.01
The mammographic density of a mass is a significant predictor of breast cancer. Radiology (2010) 1.00
Antidepressant medication use and breast cancer risk. Pharmacoepidemiol Drug Saf (2009) 1.00
Trends of postmenopausal estrogen plus progestin prevalence in the United States between 1970 and 2010. Obstet Gynecol (2014) 0.99
Developing a claim-based version of the ACE-27 comorbidity index: a comparison with medical record review. Med Care (2011) 0.99
Circulating sex hormones and mammographic breast density among postmenopausal women. Horm Cancer (2011) 0.98
A comprehensive methodology for determining the most informative mammographic features. J Digit Imaging (2013) 0.98
Dose-response relationships between physical activity, social participation, and health-related quality of life in colorectal cancer survivors. J Cancer Surviv (2013) 0.97
Social networks and survival after breast cancer diagnosis. J Cancer Surviv (2010) 0.97
Predictors of family conflict at the end of life: the experience of spouses and adult children of persons with lung cancer. Gerontologist (2009) 0.97
Axial-shear strain imaging for differentiating benign and malignant breast masses. Ultrasound Med Biol (2010) 0.97
Detection method and breast carcinoma histology. Cancer (2002) 0.97
Family history and colorectal cancer survival in women. Fam Cancer (2008) 0.96
Relation of anthropometric measurements to ovarian cancer risk in a population-based case-control study (United States). Cancer Causes Control (2006) 0.96
Late age at first full term birth is strongly associated with lobular breast cancer. Cancer (2010) 0.95
To screen or not to screen women in their 40s for breast cancer: is personalized risk-based screening the answer? Ann Intern Med (2011) 0.94
No difference between red wine or white wine consumption and breast cancer risk. Cancer Epidemiol Biomarkers Prev (2009) 0.94
Dietary carotenoids and the risk of invasive breast cancer. Int J Cancer (2009) 0.93
Serum calcium and breast cancer risk in a prospective cohort study. Ann Epidemiol (2010) 0.93
Risk of breast cancer for women living in rural areas from adult exposure to atrazine from well water in Wisconsin. J Expo Sci Environ Epidemiol (2006) 0.93
Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies. Ann Intern Med (2016) 0.92
Early life risk factors in cancer: the relation of birth weight to adult obesity. Int J Cancer (2003) 0.92
Variation in diagnostic performance among radiologists at screening CT colonography. Radiology (2013) 0.91
Patterns of postmenopausal progestin use with estrogen in relation to endometrial cancer (United States). Cancer Causes Control (2003) 0.91
Score As You Lift (SAYL): A Statistical Relational Learning Approach to Uplift Modeling. Mach Learn Knowl Discov Databases (2015) 0.90
Physical activity and function in older, long-term colorectal cancer survivors. Cancer Causes Control (2009) 0.90
Occupational exposure to electromagnetic field and breast cancer risk in a large, population-based, case-control study in the United States. J Occup Environ Med (2007) 0.89
Hormone therapy and ovarian cancer: incidence and survival. Cancer Causes Control (2008) 0.88
Physical activity, white blood cell count, and lung cancer risk in a prospective cohort study. Cancer Epidemiol Biomarkers Prev (2008) 0.88
The vitamin D pathway and mammographic breast density among postmenopausal women. Breast Cancer Res Treat (2011) 0.88
Disease-free survival by treatment after a DCIS diagnosis in a population-based cohort study. Breast Cancer Res Treat (2013) 0.88
Selection bias in population-based cancer case-control studies due to incomplete sampling frame coverage. Cancer Epidemiol Biomarkers Prev (2012) 0.87